 |
 |
 |
 |
 |
 |
|
||||||||||||||
SELECT PUBLICATIONS
Colleoni M et al; International Breast Cancer Study Group. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93. J Clin Oncol 2006;24(9):1332-41. Abstract
Elledge RM. Tales from a targeted therapy. J Clin Oncol 2006;24(9):1323-5. No abstract available
Fisher B et al. Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-23. J Clin Oncol 2001;19(4):931-42. Abstract
Paik S et al. Gene expression and benefit of chemotherapy in women with nodenegative, estrogen receptor-positive breast cancer. J Clin Oncol 2006;[Epub ahead of print]. Abstract
Paik S et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351(27):2817-26. Abstract
Paik S et al. Real-world performance of HER2 testing — National Surgical Adjuvant Breast and Bowel Project experience. J Natl Cancer Inst 2002;94(11):852-4. Abstract
| Table of Contents | Top of Page |
Editor:
Neil Love, MD
Interviews
Monica Morrow, MD
- Select publications
Kevin R Fox, MD
- Select publications
Thomas B Julian, MD
- Select publications
Robert W Carlson, MD
- Select publications
Richard M Elledge, MD
- Select publications
 |
 |
 |
 |
 |
